1
|
Piña-Olmos S, Dolores-Hernández M, Diaz-Torres R, Ramírez-Bribiesca JE, López-Arellano R, López Barrera LD, Ramírez-Noguera P. Precision-cut liver slices as a model for assess hepatic cellular response of chitosan-glutathione nanoparticles on cultures treated with zilpaterol and clenbuterol. Toxicol Mech Methods 2021; 32:313-324. [PMID: 34747310 DOI: 10.1080/15376516.2021.2002992] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Zilpaterol and clenbuterol are two β-adrenergic agonist drugs used in animal production. Both drugs have anabolic effects with advantages on carcass yield. Meanwhile, zilpaterol is approved for animal feed in authorized countries. Clenbuterol is a banned substance due to the risk of toxicity; however, it is still being used in unknown dose levels in many farm species. Therefore, the use and abuse of these substances should be closely monitored, considering the clenbuterol ability and the not proved yet of zilpaterol to produce reactive oxygen and nitrogen species. Regarding glutathione which is the main intracellular antioxidant plays detoxification functions on liver metabolism; in this work, it is our interest to know the capacity of chitosan-glutathione nanoparticles (CS/GSH-NP) as a complementary source of exogenous GSH to modify the oxide-reduction status on bovine precision-cut liver slice cultures (PCLS) exposed to clenbuterol and zilpaterol. A single drug assay was performed in first instance by adding clenbuterol, zilpaterol, chitosan nanoparticles (CS-NP), and CS/GSH-NP. Then combinate drug assay was carried out by testing clenbuterol and zilpaterol combined with CS-NP or CS/GSH-NP. The results showed that both β-adrenergic agonists modify in a dose-dependent manner in oxide-reduction response through ROS generation. The activity or content of glutathione peroxidase activity, intracellular GSH, gamma glutamyl-transpeptidase, aspartate aminotrasnferase and alanine aminotrasnferase were modified. The exogenous GSH delivered by nanoparticles could be used to modulate these markers.
Collapse
Affiliation(s)
- Sofia Piña-Olmos
- Laboratorio de Toxicología Celular L-9, Unidad de Investigación Multidisciplinaria, FES-Cuautitlán, Campo 4, Carretera México-Teoloyucan Km 2.5, San Sebastián Xhala, Cuautitlán Izcalli Estado de México, México
| | - Mariana Dolores-Hernández
- Laboratorio de Desarrollo Farmacéutico (LEDEFAR), Unidad de Investigación Multidisciplinaria, FES-Cuautitlán, Campo 4, Carretera México-Teoloyucan Km 2.5, San Sebastián Xhala, Cuautitlán Izcalli Estado de México, México
| | - Roberto Diaz-Torres
- Laboratorio de Toxicología Celular L-9, Unidad de Investigación Multidisciplinaria, FES-Cuautitlán, Campo 4, Carretera México-Teoloyucan Km 2.5, San Sebastián Xhala, Cuautitlán Izcalli Estado de México, México
| | - J Efrén Ramírez-Bribiesca
- Programa de Ganadería, Colegio de Posgraduados, Montecillo, Carretera México-Texcoco Km 36.5, Montecillo, Estado de México, México
| | - Raquel López-Arellano
- Laboratorio de Desarrollo Farmacéutico (LEDEFAR), Unidad de Investigación Multidisciplinaria, FES-Cuautitlán, Campo 4, Carretera México-Teoloyucan Km 2.5, San Sebastián Xhala, Cuautitlán Izcalli Estado de México, México
| | - Laura Denise López Barrera
- Laboratorio de Toxicología Celular L-9, Unidad de Investigación Multidisciplinaria, FES-Cuautitlán, Campo 4, Carretera México-Teoloyucan Km 2.5, San Sebastián Xhala, Cuautitlán Izcalli Estado de México, México
| | - Patricia Ramírez-Noguera
- Laboratorio de Toxicología Celular L-9, Unidad de Investigación Multidisciplinaria, FES-Cuautitlán, Campo 4, Carretera México-Teoloyucan Km 2.5, San Sebastián Xhala, Cuautitlán Izcalli Estado de México, México
| |
Collapse
|